Show
Sort by
-
- Journal Article
- A1
- open access
CRISPR/Cas9 screen in human iPSC-derived cortical neurons identifies NEK6 as a novel disease modifier of C9orf72 poly(PR) toxicity
-
Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT) : a randomised, double-blind, phase 3 trial
-
- Journal Article
- A1
- open access
Immunogenicity and safety of a 3-antigen hepatitis B vaccine vs a single-antigen hepatitis B vaccine : a phase 3 randomized clinical trial
-
- Journal Article
- A1
- open access
Interim results of a phase 1-2a trial of Ad26.COV2.S Covid-19 vaccine
-
- Journal Article
- A1
- open access
Late-onset Pompe disease (LOPD) in Belgium : clinical characteristics and outcome measures
-
A phase 3 multicenter, prospective, open-label efficacy and safety study of immune globulin (human) 10% caprylate/chromatography purified in patients with myasthenia gravis exacerbations
-
- Journal Article
- A1
- open access
FUS-induced neurotoxicity in Drosophila is prevented by downregulating nucleocytoplasmic transport proteins
-
- Journal Article
- A1
- open access
A zebrafish model for C9orf72 ALS reveals RNA toxicity as a pathogenic mechanism
-
- Journal Article
- A1
- open access
Molecular dissection of FUS points at synergistic effect of low-complexity domains in toxicity
-
- Journal Article
- A1
- open access
Inside out : the role of nucleocytoplasmic transport in ALS and FTLD
-
- Journal Article
- A1
- open access
Sustained low rotavirus activity and hospitalisation rates in the post-vaccination era in Belgium, 2007 to 2014
-
Database crossing allows better understanding of neuromuscular disorders epidemiology: the Belgian example
-
- Journal Article
- A1
- open access
Drosophila screen connects nuclear transport genes to DPR pathology in c9ALS/FTD
-
The disease burden of hepatitis C in Belgium: an update of a realistic disease control strategy
-
Development of a disease severity scale for Becker muscular dystrophy